首页 > 最新文献

Medical Principles and Practice最新文献

英文 中文
Takotsubo Syndrome Recurrence: A Trigger for Increased 30-Day Cardiovascular Mortality. Takotsubo综合征复发是30天心血管死亡率增加的诱因
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-04-01 DOI: 10.1159/000545544
Albert Topf, Moritz Mirna, Uta C Hoppe, Michael Lichtenauer, Lukas Motloch, Ravi Vazirani, Sabine Horn, Iván J Núñez-Gil

Objectives: Recurrence of Takotsubo syndrome (TTS) has been reported with a rate up to 4%. The effect of TTS recurrence on clinical outcomes has not been in the focus of studies so far.

Methods: In our study, we enrolled 435 patients with TTS, of whom 14 patients had a recurrence. The inclusion interval for the index event was from 2015 to 2022, and patients were followed to categorize them in the group of TTS with or without the recurrence. TTS recurrences were registered until June 2024. Blood samples, data on clinical presentation, precipitating factors, cardiovascular risk factors, medications, demographics, echocardiographic and electrocardiographic parameters were obtained. The 30-day cardiovascular mortality (CV), the 30-day mortality, and arrhythmia during hospitalization were evaluated.

Results: Comorbidities, ECG changes, premedication, and symptoms were not significantly different between TTS patients with and without recurrence. Only the index left ventricular ejection fraction (LVEF) of TTS patients with recurrence was significantly decreased (p = 0.046). In the case of outcome parameters, TTS patients with recurrence had a significantly, higher 30-day CV mortality compared to those without recurrence (21.4% vs. 3.8%, p = 0.001) with a 5.9-fold higher 30-day CV mortality (B(SE) = 1.94 (0.70), p = 0.001).

Conclusion: In our study, the TTS recurrence was associated with 5.9-fold higher 30-day CV mortality. Therefore, a more precise monitoring is necessary in this high-risk group. Whether only the reduced LVEF is responsible for the increased 30-day CV mortality is an open issue and more factors can be assumed to play a role.

目的:Takotsubo综合征(TTS)的复发率高达4%。TTS复发对临床预后的影响目前还不是研究的重点。方法:在我们的研究中,我们纳入了435例TTS患者,其中14例复发。指标事件的纳入时间间隔为2015 - 2022年,随访患者并将其分为有无复发的TTS组。TTS复发记录到2024年6月。获得血液样本、临床表现、诱发因素、心血管危险因素、药物、人口统计学、超声心动图和心电图参数等数据。观察住院30天心血管死亡率(CV)、30天死亡率和心律失常。结果:有无复发TTS患者的合并症、心电图改变、用药前及症状无显著差异。复发TTS患者仅左室射血分数指数(LVEF)显著降低(p = 0.046)。在结果参数方面,复发的TTS患者的30天cv死亡率明显高于无复发的TTS患者(21.4% vs 3.8%, p = 0.001), 30天cv死亡率高出5.9倍(B(SE)= 1.94(0.70), p = 0.001)。结论:在我们的研究中,TTS复发与5.9倍高的30天cv死亡率相关。因此,对这一高危人群进行更精确的监测是必要的。是否仅仅是LVEF的降低导致了30天cv死亡率的增加,这是一个悬而未决的问题,可以假设有更多的因素在起作用。
{"title":"Takotsubo Syndrome Recurrence: A Trigger for Increased 30-Day Cardiovascular Mortality.","authors":"Albert Topf, Moritz Mirna, Uta C Hoppe, Michael Lichtenauer, Lukas Motloch, Ravi Vazirani, Sabine Horn, Iván J Núñez-Gil","doi":"10.1159/000545544","DOIUrl":"10.1159/000545544","url":null,"abstract":"<p><strong>Objectives: </strong>Recurrence of Takotsubo syndrome (TTS) has been reported with a rate up to 4%. The effect of TTS recurrence on clinical outcomes has not been in the focus of studies so far.</p><p><strong>Methods: </strong>In our study, we enrolled 435 patients with TTS, of whom 14 patients had a recurrence. The inclusion interval for the index event was from 2015 to 2022, and patients were followed to categorize them in the group of TTS with or without the recurrence. TTS recurrences were registered until June 2024. Blood samples, data on clinical presentation, precipitating factors, cardiovascular risk factors, medications, demographics, echocardiographic and electrocardiographic parameters were obtained. The 30-day cardiovascular mortality (CV), the 30-day mortality, and arrhythmia during hospitalization were evaluated.</p><p><strong>Results: </strong>Comorbidities, ECG changes, premedication, and symptoms were not significantly different between TTS patients with and without recurrence. Only the index left ventricular ejection fraction (LVEF) of TTS patients with recurrence was significantly decreased (p = 0.046). In the case of outcome parameters, TTS patients with recurrence had a significantly, higher 30-day CV mortality compared to those without recurrence (21.4% vs. 3.8%, p = 0.001) with a 5.9-fold higher 30-day CV mortality (B(SE) = 1.94 (0.70), p = 0.001).</p><p><strong>Conclusion: </strong>In our study, the TTS recurrence was associated with 5.9-fold higher 30-day CV mortality. Therefore, a more precise monitoring is necessary in this high-risk group. Whether only the reduced LVEF is responsible for the increased 30-day CV mortality is an open issue and more factors can be assumed to play a role.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"391-399"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143764412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter on "Plasma Sodium and Laboratory Parameters in Determining Complicated Appendicitis in Children". 对 "确定儿童并发阑尾炎的血浆钠和实验室参数 "信件的回复。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-10-04 DOI: 10.1159/000541749
Zlatan Zvizdic, Asmir Jonuzi, Una Glamoclija, Semir Vranic
{"title":"Response to the Letter on \"Plasma Sodium and Laboratory Parameters in Determining Complicated Appendicitis in Children\".","authors":"Zlatan Zvizdic, Asmir Jonuzi, Una Glamoclija, Semir Vranic","doi":"10.1159/000541749","DOIUrl":"10.1159/000541749","url":null,"abstract":"","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"98-99"},"PeriodicalIF":2.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11805539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adult Patients with HbS-Only Phenotype of Sickle Cell Disease Have a Decreased Arginine/Asymmetric Dimethylarginine Ratio. 成年hbs型镰状细胞病患者精氨酸/不对称二甲基精氨酸比例降低。
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-04-23 DOI: 10.1159/000546047
Angela Ugwu, Chiemelie Raluchukwu Onwasigwe, Angela Ogechukwu Ugwu, Anazoeze Jude Madu, Ikechukwu Okwudili Anigbogu, Chidiebele Michael Egolum

Introduction: Leg ulcer is the most common cutaneous manifestation of sickle cell disease (SCD). Asymmetric dimethylarginine (ADMA) inhibits nitric oxide synthase, reducing nitric oxide availability, and causing endothelial dysfunction. This study examined the relationship between arginine/ADMA ratio and leg ulcers in SCD.

Methods: This was a cross-sectional analytical study of 90 adult subjects including 30 "HbS only" with leg ulcer, 30 "HbS only" without leg ulcer and 30 HbAA subjects. Plasma arginine and ADMA levels were measured by ELISA method.

Results: Median arginine level, ADMA level, and arginine/ADMA ratio were 21.05 µmol/L, 3.0 µmol/L, and 7.41, respectively, for HbS-only with leg ulcer; 25.9 µmol/L, 2.8 µmol/L, and 9.6, respectively, for HbS-only without leg ulcer; and 47.8 µmol/L, 1.0 µmol/L (CI: 1.0-1.2), and 48.5, respectively, for HbAA subjects. Median plasma l-arginine level was significantly lower in HbS with leg ulcer compared to HbS without leg ulcer (p < 0.001) and HbAA subjects (p < 0.001). Conversely, median plasma ADMA level was significantly higher in HbS-only with leg ulcer compared to HbS without leg ulcer (p = 0.002), and HbAA subjects (p < 0.001). Median arginine/ADMA ratio was significantly lower in HbS-only patients with leg ulcer.

Conclusion: The HbS-only patients with leg ulcers have lower arginine, higher ADMA, and lower arginine/ADMA ratio when compared to those without leg ulcers and HbAA controls. The prospective arginine/ADMA ratio should be studied to screen patients with higher risks of leg ulcers that could be prevented with specifically targeted care.

.

目的:腿部溃疡是镰状细胞病(SCD)最常见的皮肤表现。不对称二甲基精氨酸(ADMA)抑制一氧化氮合酶,降低一氧化氮的可用性并引起内皮功能障碍。本研究探讨了精氨酸/ADMA比值与SCD患者腿部溃疡之间的关系。方法:这是一项对90名成人受试者的横断面分析研究,包括30名“仅HbS”伴有腿部溃疡,30名“仅HbS”无腿部溃疡和30名HbAA受试者。ELISA法测定血浆精氨酸和ADMA水平。结果:HbS-Only腿部溃疡患者精氨酸水平、ADMA水平和精氨酸/ADMA比值的中位数分别为21.05、3.0和7.41 μ mol/L;无腿部溃疡的HbS-Only分别为25.9µmol/L、2.8µmol/L和9.6µmol/L;HbAA组分别为47.8µmol/L、1.0µmol/L (CI 1.0 ~ 1.2)、48.5。有腿溃疡的HbS患者血浆中位l -精氨酸水平显著低于无腿溃疡的HbS患者(p < 0.001)和HbAA患者(p < 0.001)。相反,与没有腿部溃疡的HbS和HbAA受试者相比,仅HbS患者的中位血浆ADMA水平显著高于没有腿部溃疡的HbS (p = 0.002)和HbAA受试者(p < 0.001)。在只有hbs的腿部溃疡患者中,精氨酸/ADMA的中位数比值显著降低。结论:与没有腿部溃疡和HbAA对照的患者相比,只有HbAA的腿部溃疡患者的Arginine较低,ADMA较高,Arginine/ADMA比值较低。应研究预期精氨酸/ADMA比值,以筛选可通过针对性护理预防的较高腿部溃疡风险患者。
{"title":"Adult Patients with HbS-Only Phenotype of Sickle Cell Disease Have a Decreased Arginine/Asymmetric Dimethylarginine Ratio.","authors":"Angela Ugwu, Chiemelie Raluchukwu Onwasigwe, Angela Ogechukwu Ugwu, Anazoeze Jude Madu, Ikechukwu Okwudili Anigbogu, Chidiebele Michael Egolum","doi":"10.1159/000546047","DOIUrl":"10.1159/000546047","url":null,"abstract":"<p><p><p>Introduction: Leg ulcer is the most common cutaneous manifestation of sickle cell disease (SCD). Asymmetric dimethylarginine (ADMA) inhibits nitric oxide synthase, reducing nitric oxide availability, and causing endothelial dysfunction. This study examined the relationship between arginine/ADMA ratio and leg ulcers in SCD.</p><p><strong>Methods: </strong>This was a cross-sectional analytical study of 90 adult subjects including 30 \"HbS only\" with leg ulcer, 30 \"HbS only\" without leg ulcer and 30 HbAA subjects. Plasma arginine and ADMA levels were measured by ELISA method.</p><p><strong>Results: </strong>Median arginine level, ADMA level, and arginine/ADMA ratio were 21.05 µmol/L, 3.0 µmol/L, and 7.41, respectively, for HbS-only with leg ulcer; 25.9 µmol/L, 2.8 µmol/L, and 9.6, respectively, for HbS-only without leg ulcer; and 47.8 µmol/L, 1.0 µmol/L (CI: 1.0-1.2), and 48.5, respectively, for HbAA subjects. Median plasma <sc>l</sc>-arginine level was significantly lower in HbS with leg ulcer compared to HbS without leg ulcer (p < 0.001) and HbAA subjects (p < 0.001). Conversely, median plasma ADMA level was significantly higher in HbS-only with leg ulcer compared to HbS without leg ulcer (p = 0.002), and HbAA subjects (p < 0.001). Median arginine/ADMA ratio was significantly lower in HbS-only patients with leg ulcer.</p><p><strong>Conclusion: </strong>The HbS-only patients with leg ulcers have lower arginine, higher ADMA, and lower arginine/ADMA ratio when compared to those without leg ulcers and HbAA controls. The prospective arginine/ADMA ratio should be studied to screen patients with higher risks of leg ulcers that could be prevented with specifically targeted care. </p>.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"483-490"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144031368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Sublethal Disinfectant Exposure on Antibiotic Resistance Patterns of Pseudomonasaeruginosa. 亚致死消毒剂暴露对铜绿假单胞菌抗生素耐药性模式的影响
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-11-13 DOI: 10.1159/000542322
Mohemid Maddallah Al-Jebouri

Objective: The problem of hospital cross-infection due to contamination of disinfectants has been recognized elsewhere. The passage of bacteria through diluted disinfectants may not only bring about phenotypic changes in their antibiograms but also changes in phage susceptibility patterns. Contact with disinfectants in sublethal concentrations allows survival and multiplication of bacteria.

Methods and materials: Serial passage, through disinfectants at subminimal inhibitory concentrations, induced antibiotic resistance in 18% of derived phenotypic variants of fifty strains of Pseudomonas aeruginosa which were isolated from diarrheal stools of infants in children's hospital.

Results: A proportion of these strains became susceptible to an increased number of antibiotics. The present study revealed that all the isolates were resistant to tetracycline and carbenicillin and 40% of these isolates became sensitive to both antibiotics after exposure to disinfectants. The exposure to disinfectants induced neomycin resistance among two isolates. The resistance patterns were three before disinfectants exposure which increased to be nine different patterns after exposure. No antibiotic resistance was transferred between P. aeruginosa and Escherichia coli K12 as a recipient strain.

Conclusions: Almost 50% of the isolates tested became sensitive to tetracycline, carbenicillin and co-trimoxazole after exposure to disinfectants. The resistance patterns among the 50 isolates were three which changed to be nine different patterns after exposure to disinfectants. Unjustifiable use of disinfectants might give a chance for survival and multiplication of pathogenic bacteria to develop new resistance patterns to antibiotics in use with a short time. These new resistance variants of bacteria which multiply in hospital environment could lead to serious epidemic conflicts particularly the epidemiological reporting and management.

Objective: The problem of hospital cross-infection due to contamination of disinfectants has been recognized elsewhere. The passage of bacteria through diluted disinfectants may not only bring about phenotypic changes in their antibiograms but also changes in phage susceptibility patterns. Contact with disinfectants in sublethal concentrations allows survival and multiplication of bacteria.

Methods and materials: Serial passage, through disinfectants at subminimal inhibitory concentrations, induced antibiotic resistance in 18% of derived phenotypic variants of fifty strains of Pseudomonas aeruginosa which were isolated from diarrheal stools of infants in children's hospital.

Results: A proportion of these strains became susceptible to an increased number of antibiotics. The present study revealed that all the isolates were resistant to tetracycline and carbenicillin and 40% of these isolate

目的:消毒剂污染造成的医院交叉感染问题已在其他地方得到公认。细菌通过稀释的消毒剂不仅会导致其抗生素图谱的表型变化,还会导致噬菌体敏感性模式的变化。与亚致死浓度的消毒剂接触可使细菌存活和繁殖:方法和材料:从儿童医院的婴儿腹泻粪便中分离出的 50 株铜绿假单胞菌,其表型变异中有 18% 的细菌通过亚致死浓度的消毒剂后产生了抗生素耐药性:结果:这些菌株中有一部分对越来越多的抗生素产生了敏感性。本研究显示,所有分离菌株都对四环素和羧苄西林产生耐药性,其中 40% 的分离菌株在接触消毒剂后对这两种抗生素变得敏感。两个分离物对消毒剂产生了新霉素耐药性。在接触消毒剂之前,耐药性模式有三种,接触消毒剂之后,耐药性模式增加到九种。铜绿假单胞菌和大肠杆菌 K12 作为接受菌株之间没有抗生素耐药性转移:结论:近 50%的受检分离菌株在接触消毒剂后对四环素、羧苄西林和联合曲唑变得敏感。50 个分离菌株的抗药性模式有三种,在接触消毒剂后又变为九种不同的模式。不合理地使用消毒剂可能会给病原菌提供生存和繁殖的机会,使其在短时间内对使用中的抗生素产生新的抗药性。这些在医院环境中繁殖的细菌的新抗药性变种可能会导致严重的流行病冲突,特别是在流行病学报告和管理方面。
{"title":"Impact of Sublethal Disinfectant Exposure on Antibiotic Resistance Patterns of Pseudomonasaeruginosa.","authors":"Mohemid Maddallah Al-Jebouri","doi":"10.1159/000542322","DOIUrl":"10.1159/000542322","url":null,"abstract":"<p><strong>Objective: </strong>The problem of hospital cross-infection due to contamination of disinfectants has been recognized elsewhere. The passage of bacteria through diluted disinfectants may not only bring about phenotypic changes in their antibiograms but also changes in phage susceptibility patterns. Contact with disinfectants in sublethal concentrations allows survival and multiplication of bacteria.</p><p><strong>Methods and materials: </strong>Serial passage, through disinfectants at subminimal inhibitory concentrations, induced antibiotic resistance in 18% of derived phenotypic variants of fifty strains of Pseudomonas aeruginosa which were isolated from diarrheal stools of infants in children's hospital.</p><p><strong>Results: </strong>A proportion of these strains became susceptible to an increased number of antibiotics. The present study revealed that all the isolates were resistant to tetracycline and carbenicillin and 40% of these isolates became sensitive to both antibiotics after exposure to disinfectants. The exposure to disinfectants induced neomycin resistance among two isolates. The resistance patterns were three before disinfectants exposure which increased to be nine different patterns after exposure. No antibiotic resistance was transferred between P. aeruginosa and Escherichia coli K12 as a recipient strain.</p><p><strong>Conclusions: </strong>Almost 50% of the isolates tested became sensitive to tetracycline, carbenicillin and co-trimoxazole after exposure to disinfectants. The resistance patterns among the 50 isolates were three which changed to be nine different patterns after exposure to disinfectants. Unjustifiable use of disinfectants might give a chance for survival and multiplication of pathogenic bacteria to develop new resistance patterns to antibiotics in use with a short time. These new resistance variants of bacteria which multiply in hospital environment could lead to serious epidemic conflicts particularly the epidemiological reporting and management.</p><p><strong>Objective: </strong>The problem of hospital cross-infection due to contamination of disinfectants has been recognized elsewhere. The passage of bacteria through diluted disinfectants may not only bring about phenotypic changes in their antibiograms but also changes in phage susceptibility patterns. Contact with disinfectants in sublethal concentrations allows survival and multiplication of bacteria.</p><p><strong>Methods and materials: </strong>Serial passage, through disinfectants at subminimal inhibitory concentrations, induced antibiotic resistance in 18% of derived phenotypic variants of fifty strains of Pseudomonas aeruginosa which were isolated from diarrheal stools of infants in children's hospital.</p><p><strong>Results: </strong>A proportion of these strains became susceptible to an increased number of antibiotics. The present study revealed that all the isolates were resistant to tetracycline and carbenicillin and 40% of these isolate","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"172-178"},"PeriodicalIF":2.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11936435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19. 吸入阿维他地尔是COVID-19肺损伤恢复的新希望。
IF 2.9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-01-27 DOI: 10.1159/000543773
Dorina Esendagli, Nuran Sarı, Sıla Akhan, Sonay Arslan, İrem Asena Doğan Öntaş, Gürdal Yılmaz, Firdevs Aksoy, Aydın Kant, Kadriye Kart Yaşar, Esra Canbolat Ünlü, Işıl Kibar Akıllı, Mustafa Kemal Çelen, Çiğdem Mermutluoğlu, Saim Dayan, Emre Kara, Gamze Durhan, Serhat Ünal, Barış Demirkol, Levent Arafat, Erdoğan Çetinkaya, Mustafa Çörtük, Nagihan Durmuş Koçak, Elif Torun Parmaksız, Ahmet Çağkan İnkaya

Objective: We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to investigate the short- and long-term effects of inhaled aviptadil on hospitalized, adult COVID-19 patients.

Methods: A multicenter, prospective, placebo-controlled, comparative, randomized, double-blind clinical trial was conducted. Patients were randomized 1:1 to either inhaled aviptadil or placebo, in addition to the standard care. The primary endpoint is the time from hospitalization to discharge within 30 days of treatment. The secondary endpoints are clinical and radiological score improvements.

Results: The study involved 80 patients enrolled from 9 clinical centers. The mean age was 55.8 ± 18.5 years, and 27 of them (33.8%) were female. The average time to discharge was 7.8 ± 4.0 days in aviptadil group and 10 ± 5.0 days in placebo (p = 0.049). Modified Borg scales were not statistically different on day 3 (p = 0.090), but significantly lower in the aviptadil group on day 7 (p = 0.033). The CT lung damage score was not different on day 1 for both groups (p = 0.962); improvement on day 28 was significantly greater in the aviptadil group (p = 0.028). The death rate was also lower in the aviptadil group (5.1%) when compared to the placebo (12.2%). There was no drop-out due to side effects.

Conclusion: Study shows that inhaled aviptadil is well tolerated and can be used as a supplementary intervention to fasten the recovery of respiratory manifestations in hospitalized patients for COVID-19 pneumonia.

Objective: We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to investigate the short- and long-term effects of inhaled aviptadil on hospitalized, adult COVID-19 patients.

Methods: A multicenter, prospective, placebo-controlled, comparative, randomized, double-blind clinical trial was conducted. Patients were randomized 1:1 to either inhaled aviptadil or placebo, in addition to the standard care. The primary endpoint is the time from hospitalization to discharge within 30 days of treatment. The secondary endpoints are clinical and radiological score improvements.

Results: The study involved 80 patients enrolled from 9 clinical centers. The mean age was 55.8 ± 18.5 years, and 27 of them (33.8%) were female. The average time to discharge was 7.8 ± 4.0 days in aviptadil group and 10 ± 5.0 days in placebo (p = 0.049). Modified Borg scales were not statistically different on day 3 (p = 0.090), but significantly lower in the aviptadil group on day 7 (p = 0.033). The CT lung damage score was not different on day 1 for both groups (p = 0.962); improvement on day 28 was significantly

目的:我们仍在寻找新的COVID-19治疗方案,以预防新感染,实现快速康复,减少长期症状或后遗症。本研究旨在探讨吸入阿维他地尔对住院成人COVID-19患者的短期和长期影响。方法:采用多中心、前瞻性、安慰剂对照、比较、随机、双盲临床试验。除标准治疗外,患者按1:1随机分为吸入阿维他地尔或安慰剂组。主要终点是治疗30天内从住院到出院的时间。次要终点是临床和放射学评分的改善。结果:该研究纳入了来自9个临床中心的80名患者。平均年龄55.8±18.5岁,女性27例(33.8%)。阿维他地尔组平均出院时间为7.8±4.0 d,安慰剂组平均出院时间为10±5.0 d (p = 0.049)。修正博格量表在第3天无统计学差异(p = 0.090),但在第7天阿维地尔组显著降低(p = 0.033)。两组患者第1天CT肺损伤评分差异无统计学意义(p = 0.962);阿维他地尔组在第28天的改善明显更大(p = 0.028)。与安慰剂组(12.2%)相比,阿维他地尔组(5.1%)的死亡率也较低。没有因为副作用而退出。结论:研究表明,吸入阿维他地尔耐受性良好,可作为辅助干预措施,加快COVID-19肺炎住院患者呼吸症状的恢复。
{"title":"Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19.","authors":"Dorina Esendagli, Nuran Sarı, Sıla Akhan, Sonay Arslan, İrem Asena Doğan Öntaş, Gürdal Yılmaz, Firdevs Aksoy, Aydın Kant, Kadriye Kart Yaşar, Esra Canbolat Ünlü, Işıl Kibar Akıllı, Mustafa Kemal Çelen, Çiğdem Mermutluoğlu, Saim Dayan, Emre Kara, Gamze Durhan, Serhat Ünal, Barış Demirkol, Levent Arafat, Erdoğan Çetinkaya, Mustafa Çörtük, Nagihan Durmuş Koçak, Elif Torun Parmaksız, Ahmet Çağkan İnkaya","doi":"10.1159/000543773","DOIUrl":"10.1159/000543773","url":null,"abstract":"<p><strong>Objective: </strong>We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to investigate the short- and long-term effects of inhaled aviptadil on hospitalized, adult COVID-19 patients.</p><p><strong>Methods: </strong>A multicenter, prospective, placebo-controlled, comparative, randomized, double-blind clinical trial was conducted. Patients were randomized 1:1 to either inhaled aviptadil or placebo, in addition to the standard care. The primary endpoint is the time from hospitalization to discharge within 30 days of treatment. The secondary endpoints are clinical and radiological score improvements.</p><p><strong>Results: </strong>The study involved 80 patients enrolled from 9 clinical centers. The mean age was 55.8 ± 18.5 years, and 27 of them (33.8%) were female. The average time to discharge was 7.8 ± 4.0 days in aviptadil group and 10 ± 5.0 days in placebo (p = 0.049). Modified Borg scales were not statistically different on day 3 (p = 0.090), but significantly lower in the aviptadil group on day 7 (p = 0.033). The CT lung damage score was not different on day 1 for both groups (p = 0.962); improvement on day 28 was significantly greater in the aviptadil group (p = 0.028). The death rate was also lower in the aviptadil group (5.1%) when compared to the placebo (12.2%). There was no drop-out due to side effects.</p><p><strong>Conclusion: </strong>Study shows that inhaled aviptadil is well tolerated and can be used as a supplementary intervention to fasten the recovery of respiratory manifestations in hospitalized patients for COVID-19 pneumonia.</p><p><strong>Objective: </strong>We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to investigate the short- and long-term effects of inhaled aviptadil on hospitalized, adult COVID-19 patients.</p><p><strong>Methods: </strong>A multicenter, prospective, placebo-controlled, comparative, randomized, double-blind clinical trial was conducted. Patients were randomized 1:1 to either inhaled aviptadil or placebo, in addition to the standard care. The primary endpoint is the time from hospitalization to discharge within 30 days of treatment. The secondary endpoints are clinical and radiological score improvements.</p><p><strong>Results: </strong>The study involved 80 patients enrolled from 9 clinical centers. The mean age was 55.8 ± 18.5 years, and 27 of them (33.8%) were female. The average time to discharge was 7.8 ± 4.0 days in aviptadil group and 10 ± 5.0 days in placebo (p = 0.049). Modified Borg scales were not statistically different on day 3 (p = 0.090), but significantly lower in the aviptadil group on day 7 (p = 0.033). The CT lung damage score was not different on day 1 for both groups (p = 0.962); improvement on day 28 was significantly ","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"191-200"},"PeriodicalIF":2.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11936437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xenotransplantation of Solid Organs: Revolutionizing Transplantation through Innovation, Ethics, and Global Solutions. 实体器官异种移植:通过创新、伦理和全球解决方案革新移植。
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-04-22 DOI: 10.1159/000546031
Sami Alobaidi, Sami Alobaidi

Xenotransplantation represents a transformative solution to the global organ shortage, leveraging advances in genetic engineering, immunosuppression, and biosecurity. This review explores groundbreaking innovations such as CRISPR-Cas9 and multigene editing, which have redefined immunogenicity reduction and significantly enhanced the graft survival. Key breakthroughs, including the incorporation of human complement-regulatory proteins and α-Gal knockout strategies, have propelled xenotransplantation closer to clinical application. Ethical considerations, such as zoonotic risks and patient selection criteria, are discussed alongside international regulatory efforts to standardize safety protocols. This manuscript uniquely highlights recent preclinical and clinical achievements, such as successful pig-to-human kidney and heart transplants, which underscore the field's potential for clinical translation. By addressing current challenges, such as long-term graft viability and societal acceptance, xenotransplantation is poised to bridge critical gaps in transplantation medicine. Future directions emphasize the integration of innovative technologies and collaborative frameworks to advance clinical applications responsibly.

.

利用基因工程、免疫抑制和生物安全方面的进展,异种移植代表了解决全球器官短缺的变革性解决方案。本文综述了突破性的创新,如CRISPR-Cas9和多基因编辑,它们重新定义了免疫原性降低,并显著提高了移植物的存活率。包括人类补体调节蛋白和α-Gal敲除策略在内的关键突破,推动异种移植更接近临床应用。伦理方面的考虑,如人畜共患病风险和患者选择标准,将与国际监管努力一起讨论,以使安全协议标准化。这份手稿独特地强调了最近的临床前和临床成就,例如成功的猪到人的肾脏和心脏移植,这强调了该领域在临床转化方面的潜力。通过解决当前的挑战,如移植的长期生存能力和社会接受度,异种移植有望弥合移植医学的关键空白。未来的方向强调创新技术和协作框架的整合,以负责任地推进临床应用。
{"title":"Xenotransplantation of Solid Organs: Revolutionizing Transplantation through Innovation, Ethics, and Global Solutions.","authors":"Sami Alobaidi, Sami Alobaidi","doi":"10.1159/000546031","DOIUrl":"10.1159/000546031","url":null,"abstract":"<p><p><p>Xenotransplantation represents a transformative solution to the global organ shortage, leveraging advances in genetic engineering, immunosuppression, and biosecurity. This review explores groundbreaking innovations such as CRISPR-Cas9 and multigene editing, which have redefined immunogenicity reduction and significantly enhanced the graft survival. Key breakthroughs, including the incorporation of human complement-regulatory proteins and α-Gal knockout strategies, have propelled xenotransplantation closer to clinical application. Ethical considerations, such as zoonotic risks and patient selection criteria, are discussed alongside international regulatory efforts to standardize safety protocols. This manuscript uniquely highlights recent preclinical and clinical achievements, such as successful pig-to-human kidney and heart transplants, which underscore the field's potential for clinical translation. By addressing current challenges, such as long-term graft viability and societal acceptance, xenotransplantation is poised to bridge critical gaps in transplantation medicine. Future directions emphasize the integration of innovative technologies and collaborative frameworks to advance clinical applications responsibly. </p>.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"418-431"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between D-Dimer and Long-Term Major Adverse Cardiovascular Outcomes in Patients with Masked Hypertension. 隐蔽性高血压患者d -二聚体与长期主要心血管不良结局的关系
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-04-26 DOI: 10.1159/000546076
Ugur Kokturk, Uğur Köktürk, Hamdi Püşüroğlu, İlyas Çetin, Mustafa Umut Somuncu, Mehmet Altunova, Ahmet Avcı, Mehmet Ertürk

Objective: We investigated the relationship between D-dimer levels and long-term major adverse cardiovascular events (MACEs) in masked hypertension patients admitted to the cardiology outpatient clinic.

Methods: A total of 512 masked hypertension patients with a median 6 years of follow-up data who underwent serum D-dimer measurement in the hypertension outpatient clinic between April 2014 and June 2016 were retrospectively enrolled. The patients were stratified according to their D-dimer levels and were then divided into tertiles. Clinical outcomes were assessed for MACEs, which were defined as all-cause mortality, cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke.

Results: The long-term incidence of MACE in masked hypertension patients was higher in the highest tertile of D-dimer. In multivariable analysis, D-dimer was an independent predictor of long-term MACE in masked hypertensive patients (OR: 1.006 [1.004-1.007]; p < 0.001). Compared to the lowest tertile, MACE was approximately 3 times higher in tertile 2 and approximately 10.5 times higher in the highest tertile. In addition, MACE was approximately 3.5 times more common in tertile 3 than in tertile 2. D-dimer was able to predict MACE in patients with masked hypertension (AUC for MACE 0.778; 95% CI: 0.724-0.832; p < 0.001) based on receiver operating characteristic curve analysis. In the Kaplan-Meier curve showing follow-up without MACE (MACE free) according to the D-dimer cutoff value, the long-term incidence of MACE was significantly higher in the high D-dimer group (p < 0.001).

Conclusions: D-dimer levels in patients with masked hypertension showed a significant association with increased long-term risk of MACE in this study.

.

目的:探讨住院心脏病科门诊隐匿性高血压患者d -二聚体水平与长期主要心血管不良事件的关系。方法:回顾性纳入2014年4月至2016年6月在高血压门诊接受血清d -二聚体测定的512例中位随访6年的隐匿性高血压患者。根据患者的d -二聚体水平进行分层,然后将其分为各组。评估主要不良心血管事件(MACE)的临床结果,MACE定义为全因死亡率、心血管死亡率、非致死性心肌梗死(MI)和非致死性卒中。结果:d -二聚体浓度最高的隐匿性高血压患者MACE的长期发生率较高。在多变量分析中,d -二聚体是隐匿性高血压患者长期MACE的独立预测因子(OR: 1.006 (1.004-1.007);P < 0.001)。与最低一分土相比,二分土的MACE高约3倍,最高一分土的MACE高约10.5倍。此外,在Tertile 3中,MACE的发生率大约是Tertile 2的3.5倍。d -二聚体能够预测隐匿性高血压患者的MACE (MACE的AUC为0.778 (95% CI 0.724-0.832;P < 0.001)。在Kaplan-Meier曲线中,根据d -二聚体的截止值显示随访时无MACE(无MACE),高d -二聚体组MACE的长期发生率显著高于对照组(p < 0.001)。结论:在本研究中,隐匿性高血压患者的d -二聚体水平与MACE长期风险增加显著相关。
{"title":"Association between D-Dimer and Long-Term Major Adverse Cardiovascular Outcomes in Patients with Masked Hypertension.","authors":"Ugur Kokturk, Uğur Köktürk, Hamdi Püşüroğlu, İlyas Çetin, Mustafa Umut Somuncu, Mehmet Altunova, Ahmet Avcı, Mehmet Ertürk","doi":"10.1159/000546076","DOIUrl":"10.1159/000546076","url":null,"abstract":"<p><p><p>Objective: We investigated the relationship between D-dimer levels and long-term major adverse cardiovascular events (MACEs) in masked hypertension patients admitted to the cardiology outpatient clinic.</p><p><strong>Methods: </strong>A total of 512 masked hypertension patients with a median 6 years of follow-up data who underwent serum D-dimer measurement in the hypertension outpatient clinic between April 2014 and June 2016 were retrospectively enrolled. The patients were stratified according to their D-dimer levels and were then divided into tertiles. Clinical outcomes were assessed for MACEs, which were defined as all-cause mortality, cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke.</p><p><strong>Results: </strong>The long-term incidence of MACE in masked hypertension patients was higher in the highest tertile of D-dimer. In multivariable analysis, D-dimer was an independent predictor of long-term MACE in masked hypertensive patients (OR: 1.006 [1.004-1.007]; p < 0.001). Compared to the lowest tertile, MACE was approximately 3 times higher in tertile 2 and approximately 10.5 times higher in the highest tertile. In addition, MACE was approximately 3.5 times more common in tertile 3 than in tertile 2. D-dimer was able to predict MACE in patients with masked hypertension (AUC for MACE 0.778; 95% CI: 0.724-0.832; p < 0.001) based on receiver operating characteristic curve analysis. In the Kaplan-Meier curve showing follow-up without MACE (MACE free) according to the D-dimer cutoff value, the long-term incidence of MACE was significantly higher in the high D-dimer group (p < 0.001).</p><p><strong>Conclusions: </strong>D-dimer levels in patients with masked hypertension showed a significant association with increased long-term risk of MACE in this study. </p>.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"491-499"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Distal Radial Artery Access versus Proximal Radial Artery Access for Cardiac Procedures: A Systematic Review and Meta-Analysis. 心脏手术中桡动脉远端通路与桡动脉近端通路的疗效和安全性:系统回顾和荟萃分析。
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-02-04 DOI: 10.1159/000543817
Mohammad Ebad Ur Rehman, Hafsa Arshad Azam Raja, Muhammad Osama, Aisha Kakakhail, Muhammad Hassan Waseem, Muhammad Mukhlis, Muhammad Abdullah Ali, Zain Ul Abideen, Muhammad Shoaib, Zahir Ud Din, Ammara Tahir, Muhammad Zohaib Ul Hassan, Usman Mazhar, Syed Tehseen Haider, Sajeel Saeed, Abdulqadir J Nashwan

Objective: Cardiac catheterization using the distal radial artery (DRA) access, at the level of the anatomical snuff box post-radial artery bifurcation, may be linked to a lower rate of arterial occlusion and better hemostasis. In this meta-analysis, we compare DRA versus proximal radial artery (PRA) access in cardiac catheterization or angiography.

Methods: A detailed literature search was performed on PubMed, Cochrane, Embase, and Clinicaltrials.gov from inception till June 2024. Risk ratios (RRs) and mean differences (MDs) were pooled for categorical and continuous outcomes, respectively. Random effects meta-analysis was undertaken on RevMan.

Results: Our meta-analyses include 21 randomized controlled trials with 9,539 patients (DRA 4,761, PRA 4,778). DRA significantly reduced 24-h radial artery occlusion rates (RR 0.30, 95% CI: 0.23 to 0.40, p ≤ 0.00001) and time to hemostasis (minutes) (MD -44.46, 95% CI: -50.64 to -38.92, p < 0.00001), whereas PRA was significantly superior in terms of the puncture success rate (RR 0.96, 95% CI: 0.93 to 0.99, p < 0.01), the crossover rate (RR 2.89, 95% CI: 2.02 to 4.15, p < 0.00001), and puncture attempts (MD 0.69, 95% CI: 0.37 to 1.00, p = 0.00001).

Conclusion: DRA was associated with a lower risk of occlusion and lower time to hemostasis, but required a greater number of puncture attempts and had lower success rate. Further research is required to elucidate the most optimal approach.

目的:桡动脉分叉后解剖鼻烟盒水平桡动脉远端通道(DRA)心导管置入可降低动脉闭塞率,改善止血效果。在这项荟萃分析中,我们比较了DRA和近端桡动脉通路(PRA)在心导管或血管造影中的应用。方法:检索PubMed、Cochrane、Embase和Clinicaltrials.gov网站自成立至2024年6月的详细文献。分别汇总分类结局和连续结局的风险比(RR)和平均差异(MD)。对Revman进行随机效应meta分析。结果:我们的荟萃分析包括21项随机对照试验,共9,539例患者(DRA 4,761, PRA 4,778)。半径标注显著降低24小时桡动脉闭塞(RAO)率(相对危险度0.30,95%可信区间0.23到0.40,p≤0.00001),和止血时间(分钟)(MD -44.46, 95%可信区间-50.64到-38.92,p < 0.00001),而PRA明显优越的穿刺成功率(相对危险度0.96,95%可信区间0.93到0.99,p < 0.01),交叉率(相对危险度2.89,95%可信区间2.02到4.15,p < 0.00001,穿刺尝试(MD 0.69, 95%可信区间0.37到1.00,p = 0.00001)。结论:DRA闭塞风险较低,止血时间较短,但穿刺次数较多,成功率较低。需要进一步的研究来阐明最优的方法。
{"title":"Efficacy and Safety of Distal Radial Artery Access versus Proximal Radial Artery Access for Cardiac Procedures: A Systematic Review and Meta-Analysis.","authors":"Mohammad Ebad Ur Rehman, Hafsa Arshad Azam Raja, Muhammad Osama, Aisha Kakakhail, Muhammad Hassan Waseem, Muhammad Mukhlis, Muhammad Abdullah Ali, Zain Ul Abideen, Muhammad Shoaib, Zahir Ud Din, Ammara Tahir, Muhammad Zohaib Ul Hassan, Usman Mazhar, Syed Tehseen Haider, Sajeel Saeed, Abdulqadir J Nashwan","doi":"10.1159/000543817","DOIUrl":"10.1159/000543817","url":null,"abstract":"<p><strong>Objective: </strong>Cardiac catheterization using the distal radial artery (DRA) access, at the level of the anatomical snuff box post-radial artery bifurcation, may be linked to a lower rate of arterial occlusion and better hemostasis. In this meta-analysis, we compare DRA versus proximal radial artery (PRA) access in cardiac catheterization or angiography.</p><p><strong>Methods: </strong>A detailed literature search was performed on PubMed, Cochrane, Embase, and Clinicaltrials.gov from inception till June 2024. Risk ratios (RRs) and mean differences (MDs) were pooled for categorical and continuous outcomes, respectively. Random effects meta-analysis was undertaken on RevMan.</p><p><strong>Results: </strong>Our meta-analyses include 21 randomized controlled trials with 9,539 patients (DRA 4,761, PRA 4,778). DRA significantly reduced 24-h radial artery occlusion rates (RR 0.30, 95% CI: 0.23 to 0.40, p ≤ 0.00001) and time to hemostasis (minutes) (MD -44.46, 95% CI: -50.64 to -38.92, p < 0.00001), whereas PRA was significantly superior in terms of the puncture success rate (RR 0.96, 95% CI: 0.93 to 0.99, p < 0.01), the crossover rate (RR 2.89, 95% CI: 2.02 to 4.15, p < 0.00001), and puncture attempts (MD 0.69, 95% CI: 0.37 to 1.00, p = 0.00001).</p><p><strong>Conclusion: </strong>DRA was associated with a lower risk of occlusion and lower time to hemostasis, but required a greater number of puncture attempts and had lower success rate. Further research is required to elucidate the most optimal approach.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"328-337"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143189596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Trends and Challenges in Global Health Dental Education: Scoping Review. 探索全球健康牙科教育的趋势和挑战:范围审查。
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-02-12 DOI: 10.1159/000544113
Beatriz Helena Wolpe, Isabela Rodacoski, Victor Augusto Danelle, Maria Rosa Machado Prado, William Augusto Gomes de Oliveira Bellani

Oral health is vital to overall well-being but faces significant global challenges, necessitating reform in dental education. Global oral health education empowers professionals to address these issues, promoting global competencies,s and preventive approaches. The objective was to map scientific articles that approach global oral health education, its practical reality, and curricular inclusion in undergraduate dental programs. This study is a scoping review following the Joanna Briggs Institute's approach, with searches in databases such as PubMed and SciELO using the keywords "global health" and "education, dental," along with the Boolean operator AND. After excluding studies outside of the scope of the research and duplicate articles, 26 articles were selected for analysis. Among the analyzed articles, the need to further discuss the following topics was observed: trends and challenges in global dental education, oral health inequalities and the need for global approaches, and the integrating global health into the dental curriculum. The reviewed studies highlight the importance of adapting curricula to global needs, emphasizing the integration of oral health into global health policies and the promotion of interprofessional competencies. The review underscores the need to internationalize dental education and prepare future dentists to address oral health inequalities, with global partnerships and interprofessional collaboration being essential for the success of these initiatives. The conclusion shows that global oral health education should include preventive and interdisciplinary approaches, preparing professionals for global challenges. This requires integrating global health competencies into curricula and promoting international collaborations in dental education.

口腔健康对整体福祉至关重要,但面临重大的全球挑战,需要改革牙科教育。全球口腔健康教育使专业人员能够解决这些问题,促进全球能力和预防方法。目标是绘制科学文章,接近全球口腔健康教育,其实际情况,并纳入本科牙科课程。这项研究是按照乔安娜布里格斯研究所的方法进行的范围审查,在PubMed和SciELO等数据库中使用关键词“全球健康”和“教育,牙科”以及布尔运算符“与”进行搜索。在排除研究范围以外的研究和重复文章后,选择了26篇文章进行分析。在分析的文章中,观察到有必要进一步讨论以下主题:全球牙科教育的趋势和挑战、口腔健康不平等和采用全球方法的必要性,以及将全球健康纳入牙科课程。审查的研究报告强调了使课程适应全球需要的重要性,强调将口腔卫生纳入全球卫生政策和促进专业间能力。审查强调需要使牙科教育国际化,并为未来的牙医做好准备,以解决口腔健康不平等问题,全球伙伴关系和跨专业合作对这些举措的成功至关重要。结论表明,全球口腔健康教育应包括预防和跨学科方法,为专业人员应对全球挑战做好准备。这需要将全球卫生能力纳入课程,并促进牙科教育方面的国际合作。
{"title":"Exploring Trends and Challenges in Global Health Dental Education: Scoping Review.","authors":"Beatriz Helena Wolpe, Isabela Rodacoski, Victor Augusto Danelle, Maria Rosa Machado Prado, William Augusto Gomes de Oliveira Bellani","doi":"10.1159/000544113","DOIUrl":"10.1159/000544113","url":null,"abstract":"<p><p>Oral health is vital to overall well-being but faces significant global challenges, necessitating reform in dental education. Global oral health education empowers professionals to address these issues, promoting global competencies,s and preventive approaches. The objective was to map scientific articles that approach global oral health education, its practical reality, and curricular inclusion in undergraduate dental programs. This study is a scoping review following the Joanna Briggs Institute's approach, with searches in databases such as PubMed and SciELO using the keywords \"global health\" and \"education, dental,\" along with the Boolean operator AND. After excluding studies outside of the scope of the research and duplicate articles, 26 articles were selected for analysis. Among the analyzed articles, the need to further discuss the following topics was observed: trends and challenges in global dental education, oral health inequalities and the need for global approaches, and the integrating global health into the dental curriculum. The reviewed studies highlight the importance of adapting curricula to global needs, emphasizing the integration of oral health into global health policies and the promotion of interprofessional competencies. The review underscores the need to internationalize dental education and prepare future dentists to address oral health inequalities, with global partnerships and interprofessional collaboration being essential for the success of these initiatives. The conclusion shows that global oral health education should include preventive and interdisciplinary approaches, preparing professionals for global challenges. This requires integrating global health competencies into curricula and promoting international collaborations in dental education.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"316-327"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143408601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertension in Czech Adults Aged 25-64: Prevalence, Awareness, Control, and Risk Factors in 2019 - A Cross-Sectional Study. 捷克25-64岁成年人的高血压:2019年的患病率、意识、控制和危险因素——一项横断面研究
IF 2.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2025-04-22 DOI: 10.1159/000545945
Arian Taniwall, Michala Lustigová, Jan Brož, Pavlína Krollová, Juraj Michalec, Kristýna Žejglicová, Jana Malinovská, Lucia Bučková, Juan P González-Rivas, Geraldo A Maranhao Neto, Iuliia Pavlovska, Martina Tuháčková, Lukáš Rozsíval, Jana Urbanová

Objective: This study analysed the prevalence of hypertension and its associated risk factors in Czech adults aged 25-64 using data from the 2019 European Health Examination Survey (EHES). Given the limited number of large-scale studies in Central Europe, this study provides crucial evidence to inform public health strategies. Examining gender differences and applying updated control thresholds, it provides valuable insights into hypertension management in Czechia.

Subject and methods: We conducted a cross-sectional analysis using EHES 2019 data. Participants underwent a medical examination assessing cardiovascular health, including blood pressure and blood tests. A total of 1,056 participants were included, aged 25-64 years (mean age of 44.4 ± 0.73) years and with a mean BMI of 27.6 ± 0.35 kg/m2. Hypertension was defined as systolic blood pressure and/or diastolic blood pressure (mean of the second and the third measurements, 1 min apart) ≥140/90 mm Hg and/or current antihypertensive treatment. Awareness was determined by self-reporting prior diagnosis. Control was assessed as blood pressure <130/80 mm Hg (control 1) or <140/90 mm Hg (control 2).

Results: Hypertension prevalence was 36.3%, with higher rates in males (46.0%) than in females (26.3%, p < 0.001). Awareness was 64.8% greater in females (72.0% vs. 60.9%, p = 0.027). Treatment was received by 47.6% of hypertensives, more by women (57.7% vs. 42.0%, p < 0.001). Control rates were 10.4% (control 1) and 49.4% (control 2).

Conclusion: Hypertension is common in Czech adults, with gender differences in prevalence, awareness, and treatment. Despite high awareness, treatment and control remain suboptimal, indicating the need for targeted interventions.

.

目的:本研究利用2019年欧洲健康检查调查(EHES)的数据,分析了25-64岁捷克成年人的高血压患病率及其相关危险因素。鉴于中欧大规模研究的数量有限,本研究为公共卫生战略提供了重要证据。研究性别差异并应用更新的控制阈值,为捷克的高血压管理提供了有价值的见解。研究对象和方法:采用EHES 2019数据进行横断面分析。参与者接受了评估心血管健康的医学检查,包括血压和血液检查。纳入1056名参与者,年龄25-64岁(平均年龄44.4±0.73)岁,平均体重指数(BMI)为27.6±0.35 kg/m2。高血压被定义为收缩压(SBP)和/或舒张压(DBP)(第二次和第三次测量的平均值,间隔1分钟)≥140/90 mmHg和/或当前的抗高血压治疗。意识是通过自我报告先前的诊断来确定的。结果:高血压患病率为36.3%,男性(46.0%)高于女性(26.3%,p < 0.001)。女性的知晓率为64.8%(72.0%比60.9%,p = 0.027)。高血压患者接受治疗的比例为47.6%,女性患者比例更高(57.7%比42.0%)。结论:高血压在捷克成年人中很常见,但在患病率、认知和治疗方面存在性别差异。尽管有很高的认识,但治疗和控制仍然不够理想,这表明需要有针对性的干预措施。
{"title":"Hypertension in Czech Adults Aged 25-64: Prevalence, Awareness, Control, and Risk Factors in 2019 - A Cross-Sectional Study.","authors":"Arian Taniwall, Michala Lustigová, Jan Brož, Pavlína Krollová, Juraj Michalec, Kristýna Žejglicová, Jana Malinovská, Lucia Bučková, Juan P González-Rivas, Geraldo A Maranhao Neto, Iuliia Pavlovska, Martina Tuháčková, Lukáš Rozsíval, Jana Urbanová","doi":"10.1159/000545945","DOIUrl":"10.1159/000545945","url":null,"abstract":"<p><p><p>Objective: This study analysed the prevalence of hypertension and its associated risk factors in Czech adults aged 25-64 using data from the 2019 European Health Examination Survey (EHES). Given the limited number of large-scale studies in Central Europe, this study provides crucial evidence to inform public health strategies. Examining gender differences and applying updated control thresholds, it provides valuable insights into hypertension management in Czechia.</p><p><strong>Subject and methods: </strong>We conducted a cross-sectional analysis using EHES 2019 data. Participants underwent a medical examination assessing cardiovascular health, including blood pressure and blood tests. A total of 1,056 participants were included, aged 25-64 years (mean age of 44.4 ± 0.73) years and with a mean BMI of 27.6 ± 0.35 kg/m2. Hypertension was defined as systolic blood pressure and/or diastolic blood pressure (mean of the second and the third measurements, 1 min apart) ≥140/90 mm Hg and/or current antihypertensive treatment. Awareness was determined by self-reporting prior diagnosis. Control was assessed as blood pressure <130/80 mm Hg (control 1) or <140/90 mm Hg (control 2).</p><p><strong>Results: </strong>Hypertension prevalence was 36.3%, with higher rates in males (46.0%) than in females (26.3%, p < 0.001). Awareness was 64.8% greater in females (72.0% vs. 60.9%, p = 0.027). Treatment was received by 47.6% of hypertensives, more by women (57.7% vs. 42.0%, p < 0.001). Control rates were 10.4% (control 1) and 49.4% (control 2).</p><p><strong>Conclusion: </strong>Hypertension is common in Czech adults, with gender differences in prevalence, awareness, and treatment. Despite high awareness, treatment and control remain suboptimal, indicating the need for targeted interventions. </p>.</p>","PeriodicalId":18455,"journal":{"name":"Medical Principles and Practice","volume":" ","pages":"564-574"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12148334/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143978395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Principles and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1